Gilead preps new 500-employee plant near current San Dimas site

Gilead Sciences is plotting a new, 400,000-square-foot manufacturing site near its current plant in San Dimas, CA, local media reports.

Sunshine today: The deadline for doc-payment data release arrives

Allergan’s next tug-of-war move: Attack Valeant’s rosy Q3 forecast

Salix’s Relistor has its chance to get a jump on AZ’s new constipation med

Salix Pharmaceuticals nabbed the new Relistor approval it was counting on. The FDA blessed the injectable drug as a treatment for all patients with constipation caused by opioid pain relievers, boosting its target market more than tenfold.

AbbVie to employees: We’re definitely merging with Shire, new tax rules aside

Daiichi Sankyo nabs leukemia drugmaker Ambit in $410M deal

Astellas may not have wanted Ambit Biosciences as a development partner, but fellow Japanese pharma Daiichi Sankyo wants it as an acquisition.

Daiichi Sankyo nabs leukemia drugmaker Ambit in $410 million deal

Astellas may not have wanted Ambit Biosciences as a development partner, but fellow Japanese pharma Daiichi Sankyo wants it as an acquisition.

Roche’s Perjeta helps breast cancer patients live a record-setting 15.7 months longer

Troubled AMAG snaps up fresh-from-bankruptcy Lumara in $1.25B deal

FDA slaps cardiovascular warnings on Roche/Novartis asthma blockbuster Xolair

View sitemap

ob_end_flush();